SML Genetree is a leading brand in the field of multiplex molecular technologies and multiplex clinical molecular diagnostics. Recognized as an exemplary bio-venture company in South Korea, SML Genetree has gained both domestic and global recognition for its breakthrough products. They offer a wide range of products for molecular diagnosis and genome research.

Their product pipeline includes the world's first HPV NGS diagnostic kit, multiple respiratory syndrome diagnostic kits, HLA NGS kits, STD diagnostic kits, and a Helicobacter pylori drug resistance diagnostic kit. In response to the COVID-19 pandemic, SML Genetree introduced the Ezplex® SARS CoV-2 G kit, which has obtained various certifications such as MFDS approval, EUA by the U. S.

FDA, and CE IVD certification. SML Genetree's product offerings include PCR and real-time PCR products, which enable precise and rapid identification of infections. Their Ezplex® PCR products analyze the genes of infectious agents with high accuracy and efficiency.

They also offer Next Generation Sequencing (NGS) products, which can identify genotypes, mutations, and measure disease risks. Currently, their NGS product line includes HPV and HLA diagnostic kits, with a tuberculosis diagnostic kit under development. With continuous product development and commercialization, SML Genetree remains at the forefront of molecular diagnosis and genome research, delivering innovative solutions to global healthcare challenges